Prelude Capital Management, LLC Gossamer Bio, Inc. Transaction History
Prelude Capital Management, LLC
- $1.5 Billion
- Q4 2024
A detailed history of Prelude Capital Management, LLC transactions in Gossamer Bio, Inc. stock. As of the latest transaction made, Prelude Capital Management, LLC holds 414,847 shares of GOSS stock, worth $576,637. This represents 0.02% of its overall portfolio holdings.
Number of Shares
414,847
Previous 104,612
296.56%
Holding current value
$576,637
Previous $103,000
262.14%
% of portfolio
0.02%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding GOSS
# of Institutions
116Shares Held
163MCall Options Held
821KPut Options Held
557K-
Octagon Capital Advisors LP New York, NY18.4MShares$25.5 Million3.68% of portfolio
-
Nea Management Company, LLC Timonium, MD18.1MShares$25.1 Million1.16% of portfolio
-
Vanguard Group Inc Valley Forge, PA10MShares$13.9 Million0.0% of portfolio
-
Alyeska Investment Group, L.P. Chicago, IL8.81MShares$12.2 Million0.03% of portfolio
-
Arch Venture Management, LLC Chicago, IL8.06MShares$11.2 Million4.56% of portfolio
About Gossamer Bio, Inc.
- Ticker GOSS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 93,954,000
- Market Cap $131M
- Description
- Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...